Striatal D2 dopamine receptor status in Parkinson's disease: an [18F]dopa and [11C]raclopride PET study (Q64819943)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584682%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Striatal D2 dopamine receptor status in Parkinson's disease: an [18F]dopa and [11C]raclopride PET study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584682%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

C Dentresangle

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584682%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

L Veyre

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584682%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D Le Bars

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584682%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C Pierre

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584682%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

F Lavenne

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584682%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Pollak

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584682%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J Guerin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584682%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J C Froment

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584682%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

E Brousolle

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584682%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 November 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584682%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584682%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584682%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584682%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1025-1030

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584682%20AND%20SRC:MED&resulttype=core&format=json

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

Tracing of dopamine receptors in hemiparkinsonism with positron emission tomography (PET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

[11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

In vivo studies on striatal dopamine D1 and D2 site binding in L-dopa-treated Parkinson's disease patients with and without dyskinesias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

Positron emission tomography (PET) measurements of striatal D(2) receptors in untreated Parkinson's disease patients with follow-up after 6 and 12 months' treatment with SINEMET((R)) or SINEMET((R)) CR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

Pre-synaptic and post-synaptic dopaminergic system in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

Dopamine D2 receptor density remains constant in treated Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

Dopamine receptors in human brain: autoradiographic distribution of D1 and D2 sites in Parkinson syndrome of different etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

Asymmetrical pre-synaptic and post-synpatic changes in the striatal dopamine projection in dopa naïve parkinsonism. Diagnostic implications of the D2 receptor status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

Hemiparkinsonism in a monkey after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is associated with regional ipsilateral changes in striatal dopamine D-2 receptor density

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

DA uptake sites, D1 and D2 receptors, D2 and preproenkephalin mRNAs and Fos immunoreactivity in rat striatal subregions after partial dopaminergic degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1025%3A%3AAID-MDS1020%3E3.0.CO%3B2-P

10.1002/1531-8257(199911)14:6<1025::AID-MDS1020>3.0.CO;2-P

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584682%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference